Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Olanzapine use in women with antipsychotic-induced hyperprolactinemia.

Canuso CM, Hanau M, Jhamb KK, Green AI.

Am J Psychiatry. 1998 Oct;155(10):1458. No abstract available.

PMID:
9766782
2.

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.

Kim KS, Pae CU, Chae JH, Bahk WM, Jun TY, Kim DJ, Dickson RA.

J Clin Psychiatry. 2002 May;63(5):408-13.

PMID:
12019665
3.

Hyperprolactinemia and male sexual dysfunction.

Dickson RA, Glazer WM.

J Clin Psychiatry. 1999 Feb;60(2):125. No abstract available.

PMID:
10084644
4.

Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.

Bobes J, Garc A-Portilla MP, Rejas J, Hern Ndez G, Garcia-Garcia M, Rico-Villademoros F, Porras A.

J Sex Marital Ther. 2003 Mar-Apr;29(2):125-47.

PMID:
12623765
5.

[Galactorrhea and secondary amenorrhea in hyperprolactinemia].

Wallmeroth A, Staub JJ.

Praxis (Bern 1994). 2000 Aug 24;89(34):1341-3. German. No abstract available.

PMID:
11021189
6.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
7.

Agranulocytosis and neutropenia with typical and atypical neuroleptics.

Hong X, Wang X.

Am J Psychiatry. 2001 Oct;158(10):1736-7. No abstract available.

PMID:
11579015
8.

Return of menstruation after switching from risperidone to olanzapine.

Gazzola LR, Opler LA.

J Clin Psychopharmacol. 1998 Dec;18(6):486-7. No abstract available.

PMID:
9864085
9.

Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: a case report.

Miller DE, Sebastian CS.

J Clin Psychiatry. 2005 Feb;66(2):269-70. No abstract available.

PMID:
15705020
10.

Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.

Kinon BJ, Gilmore JA, Liu H, Halbreich UM.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:69-82.

PMID:
12650682
11.

Risperidone side effects.

Conley RR.

J Clin Psychiatry. 2000;61 Suppl 8:20-3; discussion 24-5. Review.

12.
13.

Olanzapine and risperidone.

Love RC, Kelly DL.

Am J Health Syst Pharm. 2003 Mar 1;60(5):487-8; author reply 488-9. No abstract available.

PMID:
12635459
14.
15.

A crossover study of prolactin changes associated with risperidone and olanzapine.

Lin CY, Wu PL, Pariante CM, Su KP.

J Clin Psychiatry. 2006 Sep;67(9):1470. No abstract available.

PMID:
17017838
16.

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Andersen SW, Beasley C Jr, Tollefson GD.

J Clin Psychopharmacol. 1997 Oct;17(5):407-18.

PMID:
9315992
17.

The effects of risperidone and olanzapine on the indications for clozapine.

Ganguli R, Brar JS.

Psychopharmacol Bull. 1998;34(1):83-7.

PMID:
9564203
18.

Quetiapine for olanzapine-induced galactorrhea.

Kingsbury SJ, Castelo C, Abulseoud O.

Am J Psychiatry. 2002 Jun;159(6):1061. No abstract available.

PMID:
12042203
19.

Reversal of symptomatic hyperprolactinemia by aripiprazole.

Wahl R, Ostroff R.

Am J Psychiatry. 2005 Aug;162(8):1542-3. No abstract available.

PMID:
16055781
20.

Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.

Kasper S, Hale A, Azorin JM, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 2:II1-II14. No abstract available.

PMID:
10603070
Items per page

Supplemental Content

Support Center